mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.006 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.006 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.007 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
-0.089 |
0.008 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.008 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.008 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.008 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.008 |